Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
137.00    -8.00 (-5.52%)
Bid:
137.00
Ask:
140.00
Spread: 3.00 (2.19%)
Market Cap: £107.51m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Board Changes

8 Jun 2011 07:00

RNS Number : 0396I
Xaar PLC
08 June 2011
 



Xaar plc (the "Company")

 

 

Board Changes

 

 

The Company is pleased to announce the appointment of David Cheesman (68) as a Non-executive Director of the Company with effect from 4 July 2011.

 

Mr Cheesman has several non-executive positions including the Advisory Board of the London Technology Fund and was recently an advisor to Bladon Jets Ltd and Bowman Power Ltd. Between 1988 and 2007, Mr Cheesman worked for several private equity firms including Advent Venture Partners, TriTech Investment Managers and 3i plc. Before joining 3i in 1988 Mr Cheesman was managing director of Dowty Information Systems where he reorganised the management structure and significantly improved profitability. Mr Cheesman has also held several senior management and engineering roles at Prime Computer, Varian/Univac, Computer and Systems Engineering, Honeywell and UKAEA Sellafield. Mr Cheesman, a graduate electrical engineer is a Chartered Engineer and Fellow of the Institution of Engineering and Technology.

 

Mr Cheesman is replacing Robert Ecklemann whose retirement after 6 years as a Non-executive Director was set out in the Company's report and accounts.

 

Mr. Phil Lawler, Chairman, commented: "We are very please to have attracted David to join our board. His vast and in-depth technology experience will help to strengthen the board and I and my fellow board members look forward to working with him.

 

I would also like to take this opportunity to thank Robert Ecklemann for his contributions to the board and the progress Xaar has made in the past six years. The board wishes him continued success in his other ventures."

 

Further information in connection with Mr Cheesman's appointment

 

Details of public company directorships held by Mr Cheesman over the past 5 years are provided below:

 

Celoxica Plc - resigned 2 July 2008

Advent Ltd - resigned 31 December 2007

Advent Fund Managers Ltd - resigned 31 December 2007

Advent 2 Fund Managers Ltd - resigned 31 December 2007

Advent Investments Ltd - resigned 31 December 2007

Advent Management IV Ltd - resigned 31 December 2007

SPI Lasers Plc - resigned 31 October 2007

 

There are no other details to disclose under Listing Rule 9.6.13R.

 

 

For further information, please contact:

 

Xaar plc +44 (0) 1223 423 663

 

Phil Lawler - Chairman

Ian Dinwoodie - Chief Executive

Alex Bevis - Finance Director

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUBRKRANANRAR
Date   Source Headline
3rd Feb 20254:15 pmRNSTotal Voting Rights
22nd Jan 202512:30 pmRNSBlock listing Interim Review
21st Jan 20253:00 pmRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading update & notification of full year results
15th Jan 20257:00 amRNSAppointment of Chief Financial Officer
11th Dec 202410:30 amRNS2024 Full Year Trading Update
4th Dec 202410:45 amRNSUpdate statement on 2024 AGM voting results
3rd Dec 202410:50 amRNSTotal Voting Rights
20th Nov 20247:00 amRNSBoard changes
1st Nov 202412:00 pmRNSTotal Voting Rights
1st Oct 202411:30 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSInterim Results
2nd Sep 20241:45 pmRNSTotal Voting Rights
2nd Aug 20242:30 pmRNSHolding(s) in Company
1st Aug 202411:15 amRNSTotal Voting Rights
30th Jul 20247:00 amRNSNOTICE OF RESULTS AND UPDATE ON TRADING
3rd Jul 202411:45 amRNSBlock listing Interim Review
2nd Jul 20242:00 pmRNSTotal Voting Rights
28th Jun 202410:00 amRNSDirector Declaration
3rd Jun 20242:45 pmRNSTotal Voting Rights
30th May 202412:00 pmRNSBoard changes
29th May 20241:45 pmRNSResult of AGM
29th May 20249:30 amRNSHolding(s) in Company
21st May 20249:30 amRNSDirector/PDMR Shareholding
20th May 20244:30 pmRNSDirector/PDMR Shareholding
13th May 20249:42 amRNSHolding(s) in Company
1st May 20244:15 pmRNSTotal Voting Rights
30th Apr 20244:30 pmRNSDirector/PDMR Shareholding
22nd Apr 202410:51 amRNSAnnual Financial Report
2nd Apr 202412:00 pmRNSTotal Voting Rights
1st Mar 202410:15 amRNSTotal Voting Rights
26th Feb 20249:00 amRNSHolding(s) in Company
23rd Feb 202410:30 amRNSBoard Change
1st Feb 20241:32 pmRNSTotal Voting Rights
29th Jan 202412:04 pmRNSHolding(s) in Company
12th Jan 20243:15 pmRNSBlock listing Interim Review
12th Jan 20247:00 amRNSNotification of Results & Full year Guidance
8th Jan 202412:36 pmRNSTotal Voting Rights
12th Dec 20239:00 amRNSNotification of Transactions of Directors & PDMRs
11th Dec 20233:00 pmRNSNotification of Transactions of Directors & PDMRs
1st Dec 202311:00 amRNSTotal Voting Rights
1st Dec 202310:00 amRNSDirector Declaration
29th Nov 20237:00 amRNSTrading Update
17th Nov 20234:07 pmRNSHolding(s) in Company
9th Nov 20231:53 pmRNSDirector/PDMR Shareholding
3rd Nov 202310:52 amRNSHolding(s) in Company
1st Nov 20234:03 pmRNSTotal Voting Rights
30th Oct 20237:00 amRNSBoard Changes
2nd Oct 202311:45 amRNSTotal Voting Rights
21st Sep 20233:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.